Concepedia

Carolin M. Lieber

CM

Statistics

Publications

13

Citations

661

H-Index

11

Active since

2021

Affiliations

Georgia State University(Current)

Emory University

University of Georgia

University of Washington

Texas Biomedical Research Institute

Carolin M. Lieber is an author at Georgia State University specializing in infectious diseases, antiviral pharmacology, and molecular virology.

ORCID

Publications per year

2021–2024

13

Publications

13

Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets

Robert M. Cox, Josef D. Wolf, Carolin M. Lieber et al. · Nature Communications · 2021 · 131 citations · Full text

, , +14

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

Julien Sourimant, Carolin M. Lieber, Megha Aggarwal et al. · Science · 2022 · 130 citations · Full text

, , +7

4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.

Julien Sourimant, Carolin M. Lieber, Megha Aggarwal et al. · PubMed · 2022 · 57 citations · Full text

, , +15

Intestinal microbiota programming of alveolar macrophages influences severity of respiratory viral infection

Vu L. Ngo, Carolin M. Lieber, Hae-Ji Kang et al. · Cell Host & Microbe · 2024 · 57 citations · Full text

, , +16

Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection

Julia A. Brown, Katherine Z. Sanidad, Serena Lucotti et al. · Gut Microbes · 2022 · 55 citations · Full text

, , +17

1–5 of 13